# The Bachmann Protocol: A Thermo-Hydraulic Soft-Robotic Interface for Active Hemodynamic Preservation in Ischemic Limb Syndrome

**Journal Submission Draft | February 2026**

---

## Authors and Affiliations

**Yassine Drani, BSc**

AI & Machine Learning Architect | Founder & CEO, mo7ami.ai  
Independent Medical roduct  Technology Researcher  
Zurich, Switzerland | Rabat, Morocco

*Mandataire and Family of Choice to Walter Bernhard Bachmann*

*Corresponding Author: Yassine Drani  
Email: yassinedrani23@gmail.com  
GitHub: github.com/yassine-23

---

## Abstract

**Background:** Pressure-induced ischemic necrosis in immobile patients remains a significant clinical challenge despite advances in offloading technologies. Current "gold standard" interventions—including static foam offloading systems and intermittent repositioning protocols—address only mechanical pressure distribution while inadvertently exacerbating thermal accumulation and failing to compensate for the loss of the physiological venous muscle pump.

**Objective:** To present the PuzzleFlow System, a novel bio-mimetic thermo-hydraulic soft-robotic interface designed to function as an active exo-organ, addressing the complete "Triad of Failure" observed in recalcitrant ischemic limb syndrome.

**Methods:** This technical proposal derives from 365 days of continuous bedside observation of a single patient (W.B.B., 82 years) with paraplegia secondary to L1 vertebral compression fracture. Systematic analysis of treatment failures informed the reverse-engineering of four integrated subsystems: (1) Isobaric Load Redistribution via Pascal's Law fluid dynamics, (2) Active Venous Return through peristaltic pneumatic artificial muscles, (3) Targeted Isothermic Regulation via micro-fluidic heat exchange, and (4) Monolithic Antimicrobial Manufacturing using DLP elastomer printing.

**Results:** The proposed system addresses previously unrecognized failure modes of standard care: the "Incubator Effect" (Q₁₀-mediated metabolic acceleration), hydrostatic stasis from absent muscle pump function, and shear-force trauma from manual repositioning. Theoretical modeling suggests maintenance of tissue interface temperature at 32–34°C could reduce metabolic oxygen demand by 20–30%, while 0.5 Hz peristaltic compression may restore effective venous return in paralyzed extremities.

**Conclusions:** The Bachmann Protocol represents a paradigm shift from palliative offloading to active hemodynamic preservation. This bio-mimetic approach warrants clinical investigation as a potential breakthrough in ischemic limb salvage for immobile patients.

**Keywords:** Ischemic necrosis, Soft robotics, Pressure ulcer prevention, Venous stasis, Therapeutic hypothermia, McKibben actuators, Bio-mimetic engineering, Medical device innovation

---

## 1. Introduction

### 1.1 The Global Burden of Pressure-Induced Ischemic Necrosis

Pressure ulcers and ischemic necrosis in immobile patients constitute a major healthcare burden, with an estimated prevalence of 10–18% in acute care settings and up to 28% in long-term care facilities internationally¹ ². The economic cost exceeds $26 billion annually in the United States alone, with individual treatment costs ranging from $20,900 to $151,700 per ulcer depending on severity³.

Despite decades of research and the development of sophisticated offloading devices—including static foam systems, alternating-pressure mattresses, and total contact casts—recalcitrant cases continue to progress to gangrene and amputation. This persistent failure suggests that current interventions, while technically sound within their designed parameters, may be addressing an incomplete model of the underlying pathophysiology.

### 1.2 The Index Case: A Catalyst for Re-Examination

This investigation originated from the extended bedside observation of a single patient: W.B.B., an 82-year-old male who sustained an L1 vertebral compression fracture in January 2025, resulting in complete paraplegia. The first pressure injuries (*escarres*) appeared within **4 months** of the index event, despite the deployment of multiple anti-pressure mattress alternatives (*matelas anti-escarres*) including alternating-pressure systems, foam overlays, and hybrid configurations.

**Critical Context:** The rapid onset of tissue breakdown was not due to clinical negligence. Rather, it resulted from an **unavoidable therapeutic conflict** (detailed in Section 1.4) in which the orthopedic protocol for spinal fracture management directly contradicted established pressure injury prevention guidelines. The medical team appropriately prioritized bone healing, and pressure injuries became the predictable—if devastating—consequence.

The failure of "gold standard" interventions in this case prompted a systematic re-analysis of the physiological mechanisms underlying ischemic cascade in paralyzed limbs. This paper presents the findings of that analysis and proposes a novel engineering solution: the PuzzleFlow System, designed under the operational framework designated "The Bachmann Protocol."

### 1.3 The Fundamental Hypothesis

> *"We cannot cure a dynamic hemodynamic failure with static materials."*

Current offloading technologies are designed to address a single variable: external mechanical pressure. However, the ischemic cascade in paralyzed limbs is a multi-factorial pathophysiological process involving:

1. **Mechanical compression** (addressed by current technologies)
2. **Thermal dysregulation** (exacerbated by current technologies)
3. **Venous stasis** (ignored by current technologies)

This paper proposes that effective ischemic limb preservation requires an intervention that functions not as a passive cushion, but as an **Active Exo-Organ**—a device that biomimetically replaces the lost physiological functions of the paralyzed limb.

### 1.4 The Therapeutic Paradox: When Bone and Skin Compete

> *"The body was trapped—we could not simultaneously save the spine and save the skin."*

The index case revealed a fundamental and previously under-recognized clinical dilemma that we term **The Therapeutic Paradox**:

| Clinical Priority | Required Protocol | Effect on Skin |
|-------------------|-------------------|----------------|
| **Spinal Fracture Healing** | Strict bed rest on firm, flat surface; minimal repositioning to prevent vertebral displacement | Maximizes sustained pressure on bony prominences; eliminates pressure redistribution |
| **Pressure Ulcer Prevention** | Frequent repositioning (q2h); soft, pressure-redistributing surfaces; early mobilization | Risks vertebral instability; contraindicated in acute spinal injury |

**The Impossible Choice:**

Following vertebral compression fracture, standard orthopedic management mandates:
- **Supine positioning** on a firm mattress to maintain spinal alignment
- **Minimal log-rolling** to prevent secondary displacement
- **Prolonged immobilization** (weeks to months) for bone consolidation

However, these protocols create the *exact conditions* that the pressure ulcer prevention literature identifies as maximum risk factors:
- Sustained pressure over the sacrum, heels, and occiput
- Reduced repositioning frequency
- Firm surfaces without pressure redistribution

**The Clinical Reality:**

In Patient W.B.B., the medical team made the clinically appropriate decision to prioritize spinal stability. The development of pressure injuries was therefore not a failure of care, but the **predictable cost of a medically necessary trade-off**. The body, deprived of its skeletal structural integrity, could not rely on the normal biomechanics of weight distribution. The loss of the vertebral support column meant that skin complications became essentially inevitable under any static support condition.

This observation forms the core justification for the PuzzleFlow System: **a device that can provide spinal-fracture-compatible immobilization while simultaneously delivering active pressure ulcer prevention**—resolving the therapeutic paradox through engineering rather than forcing clinicians to choose which tissue system to sacrifice.

---

## 2. Clinical Observations: Identification of the "Triad of Failure"

### 2.1 Study Design

**Setting:** Private residential care, Zurich, Switzerland  
**Duration:** 365 consecutive days (January 2025 – January 2026)  
**Subject:** Single patient—W.B.B., an 82-year-old man of extraordinary dignity, whose suffering under the circumstances described above inspired this investigation  
**Primary Diagnosis:** Complete paraplegia secondary to L1 vertebral compression fracture, complicated by the therapeutic paradox described in Section 1.4  
**Observer:** Y. Drani (24-hour bedside observation under supervision of Dr. Khalid Siri, treating physician)

**Observations Recorded:**
- Tissue interface temperature (hourly)
- Dependent edema progression (daily)
- Wound healing/deterioration markers (daily)
- Positioning-related tissue trauma (per episode)
- Device compliance and failure modes

### 2.2 Results: The Three Failure Modes of Standard Care

#### 2.2.1 Failure Mode A: The Thermodynamic Paradox ("Incubator Effect")

**Observation:** Standard foam/air-cell offloading matresses function as high-efficiency thermal insulators. 

**Mechanism:** According to the Q₁₀ Temperature Coefficient⁴, each 1°C rise in tissue temperature increases metabolic oxygen demand by approximately 10%. In an ischemic limb where arterial inflow is fixed or compromised, this elevated metabolic demand rapidly outstrips available oxygen supply, shifting cellular metabolism toward anaerobic pathways and accelerating necrosis.

**Clinical Implication:** Standard offloading devices, by providing thermal insulation, paradoxically accelerate the very necrosis they are designed to prevent. The tissue is, in effect, being "incubated" in its own metabolic heat.

#### 2.2.2 Failure Mode B: Hydrostatic Stasis ("The Missing Pump")

**Observation:** Static offloading relieves mechanical *pressure* but does not address venous *flow*.

**Data:** Despite complete heel offloading (verified by pressure mapping), progressive dependent edema accumulated in the lower extremities. Circumferential leg measurements increased by an average of 1.5 cm per week during periods of immobility.

**Mechanism:** In healthy ambulatory individuals, the gastrocnemius-soleus muscle complex functions as a "second heart," compressing the deep veins during ambulation and generating the pressure gradient necessary to return blood against gravity (the Skeletal Muscle Pump)⁵. In paralyzed limbs, this pump is absent. Interstitial fluid accumulates, and the resulting hydrostatic pressure can exceed capillary closing pressure (~32 mmHg), collapsing the microcirculation from *within* even when external pressure is completely relieved.

**Clinical Implication:** External offloading alone cannot prevent ischemia when the internal hydrostatic pressure from venous stasis exceeds capillary perfusion pressure.

#### 2.2.3 Failure Mode C: Shear Force Trauma ("The Positioning Paradox")

**Observation:** Two-hourly manual repositioning, while preventing sustained pressure, creates repetitive acute shear forces.

**Data:** Photographic documentation revealed that repositioning episodes consistently resulted in micro-tears at the wound margins in fragile, granulating tissue.

**Mechanism:** Manual lifting and repositioning generates tangential forces that exceed the shear tolerance of compromised tissue (approximately 10–20% of the compressive tolerance)⁶. Each repositioning event can trigger local tissue damage and reperfusion injury, creating a cycle of micro-trauma that impedes healing.

**Clinical Implication:** The duty-cycle of conventional pressure ulcer prevention (static offloading interrupted by periodic repositioning) may be inherently traumatic for patients with severely compromised tissue integrity.

---

## 3. The Engineering Solution: The PuzzleFlow System

Based on the identification of the Triad of Failure, the PuzzleFlow System was designed as an integrated thermo-hydraulic soft-robotic interface incorporating four synergistic subsystems.

### 3.1 System Architecture Overview

| Subsystem | Target Failure Mode | Physical Principle | Biomimetic Analog |
|-----------|---------------------|-------------------|-------------------|
| Isobaric Matrix | Mechanical Compression | Pascal's Law | Synovial Fluid |
| Phantom Muscle | Venous Stasis | Peristaltic Actuation | Gastrocnemius Pump |
| Thermal Regulation | Metabolic Acceleration | Convective Heat Exchange | Arteriovenous Anastomoses |
| Monolithic Skin | Bacterial Colonization | Seamless Manufacturing | Epidermis |

### 3.2 Concept Visualization

The following figures illustrate the PuzzleFlow System design concept, demonstrating the integration of all four subsystems into a unified thermo-hydraulic soft-robotic interface.

---

**Figure 1. PuzzleFlow System — Lateral Aspect**

![Figure 1: Lateral view of the PuzzleFlow device showing the monolithic DLP-printed elastomer lattice with integrated fluid channels, pneumatic control unit with WATER IN/OUT ports, and open-cage forefoot design for wound observation.](/Users/yassinedrani/akdital/puzzleflow_lateral_view.png)

*The lateral view reveals the honeycomb lattice structure providing isobaric load distribution via Pascal's Law. The integrated control unit (visible at ankle) houses the pneumatic engine and thermal regulation system. Orange-tinted channels indicate the thermo-hydraulic circulation pathway.*

---

**Figure 2. PuzzleFlow System — Medial Aspect**

![Figure 2: Medial view demonstrating the fluid channel architecture and segmented pressure zones. Labels visible: ACTIVE THERAPY, WATER IN, WATER OUT.](/Users/yassinedrani/akdital/puzzleflow_medial_view.jpg)

*The medial aspect demonstrates the zonal architecture with distinct pressure compartments. The control unit integrates active therapy monitoring, fluid inlet (WATER IN), and fluid return (WATER OUT) ports. The green indicator confirms system activation.*

---

**Figure 3. PuzzleFlow System — Full Leg Configuration with Thermal Display**

![Figure 3: Full-leg thermo-hydraulic interface with external control unit displaying real-time temperature (32°C) in 'Metabolic Hibernation' mode.](/Users/yassinedrani/akdital/puzzleflow_full_system.png)

*The complete system extends from foot to mid-calf, incorporating the 'Phantom Muscle' actuator zone. The external control unit displays: THERMO-HYDRAULIC SYSTEM ACTIVE, TEMP: 32°C—confirming therapeutic hypothermia for metabolic demand reduction. This visualization represents the device in 'Metabolic Hibernation' mode for critical ischemia management.*

---

### 3.2 Subsystem I: Isobaric Load Redistribution

#### 3.2.1 Design Principle

The interface between device and tissue comprises a closed-loop, reticulated fluid-filled network employing Pascal's Law: *pressure applied to an enclosed fluid is transmitted undiminished to every portion of the fluid and the walls of the containing vessel*.

#### 3.2.2 Fluid Selection

A non-Newtonian, shear-thickening fluid (dilatant) is proposed as the working medium. This class of fluids exhibits the following desirable properties:

| Condition | Viscosity Behavior | Clinical Benefit |
|-----------|-------------------|------------------|
| Static (patient at rest) | Low viscosity, liquid-like | Perfect isobaric pressure distribution |
| Dynamic (movement/impact) | High viscosity, semi-solid | Structural support and protection |

Candidate fluids include cornstarch-based suspensions (for prototyping) or silicone-based proprietary suspensions (for clinical use).

#### 3.2.3 Theoretical Performance

Under ideal conditions, the isobaric matrix should maintain interface pressure below capillary closing pressure (<32 mmHg) at all anatomical points, regardless of patient position or compliance. Preliminary finite element analysis suggests that this could represent a significant improvement over static foam systems, which typically demonstrate pressure gradients of up to 60 mmHg across anatomical prominences⁷.

### 3.3 Subsystem II: The "Phantom Muscle" Actuator

#### 3.3.1 Design Principle

Integration of Pneumatic Artificial Muscles (PAMs), specifically McKibben actuators, woven into the calf interface zone. These soft-robotic actuators contract longitudinally when pressurized, mimicking the physiological action of the gastrocnemius muscle.

#### 3.3.2 Actuation Protocol

| Parameter | Specification | Rationale |
|-----------|--------------|-----------|
| Frequency | 0.5 Hz (30 cycles/min) | Approximates physiological gait cadence |
| Pressure | 20–40 mmHg | Within venous compression therapy range⁸ |
| Duty Cycle | 40s ON / 20s OFF | Prevents venous collapse from sustained compression |
| Wave Pattern | Distal-to-proximal peristalsis | Mimics natural venous return direction |

#### 3.3.3 Mechanism of Action

The rhythmic compression generates a mechanical pressure wave that:
1. Compresses the deep venous system, displacing blood toward the heart
2. Reduces interstitial hydrostatic pressure, preventing capillary collapse
3. Maintains tissue perfusion without requiring patient mobility

This mechanism is analogous to existing Intermittent Pneumatic Compression (IPC) devices used for deep vein thrombosis prophylaxis, but integrated into the offloading interface rather than applied as a separate modality.

### 3.4 Subsystem III: Targeted Isothermic Regulation

#### 3.4.1 Design Principle

The circulating fluid within the isobaric matrix doubles as a heat-exchange medium. A micro-fluidic control system maintains the tissue-device interface at a precisely regulated temperature.

#### 3.4.2 Temperature Protocol

| Tissue Status     | Target Temperature | Metabolic Effect |
|------------- -    |------------------- |------------------|
| Critical Ischemia | 32–34°C            | "Metabolic Hibernation" |
| Stable/Healing    | 34–36°C            | Optimal healing physiology |
| Acute Inflammation| 32°C               | Anti-inflammatory cooling |

#### 3.4.3 Theoretical Basis

The therapeutic target temperature of 32–34°C is derived from established principles of therapeutic hypothermia used in neuroprotection and organ preservation⁹. At this temperature range:

- Metabolic oxygen demand is reduced by approximately 6–8% per degree Celsius
- Vasoconstriction is not triggered (unlike temperatures below 30°C)
- Cellular viability is maintained for extended periods

In the context of ischemic limb tissue, this represents a strategy of *metabolic demand matching*: reducing the tissue's oxygen requirement to match the compromised arterial supply.

### 3.5 Subsystem IV: Monolithic Antimicrobial Manufacturing

#### 3.5.1 Design Principle

The complete device is manufactured as a single, seamless unit using Digital Light Processing (DLP) elastomeric 3D printing, followed by an antimicrobial dip-seal coating.

#### 3.5.2 Manufacturing Process

**Stage 1: DLP Elastomer Printing**
- Material: Biocompatible elastomeric resin (Shore hardness 50A–80A)
- Resolution: 50 µm layer thickness
- Output: Complete device with integrated internal channels

**Stage 2: Antimicrobial Dip-Seal**
- Process: Immersion in silicone/polyurethane bath containing silver nanoparticles
- Functions:
  - Seals micropores for channel airtightness
  - Provides antimicrobial surface
  - Creates smooth, low-friction skin interface

#### 3.5.3 Rationale

Conventional offloading devices (foam boots, air-cell mattresses) are characterized by:
- Multiple seams and attachment points
- Porous materials that trap moisture and microorganisms
- Difficulty in effective cleaning and sterilization

These features create favorable environments for bacterial colonization, particularly by nosocomial pathogens such as MRSA and *Pseudomonas aeruginosa*. The monolithic, non-porous construction of PuzzleFlow is designed to eliminate these colonization opportunities.

---

## 4. Adaptive Modularity: Post-Amputation Configuration

A critical design consideration is accommodation of the progressive anatomical changes common in patients with ischemic limb disease, including partial amputation.

### 4.1 Modular Architecture

The device chassis is segmented into three interlocking zones:

| Zone | Function | Interchangeability |
|------|----------|-------------------|
| **Anchor** (Rearfoot) | Pneumatic engine, heel cup, control electronics | Fixed (base unit) |
| **Bridge** (Midfoot) | Structural support | Fixed |
| **Cap** (Forefoot) | Toe coverage and wound access | Swappable |

### 4.2 Forefoot Module Variants

| Variant | Configuration | Clinical Indication |
|---------|--------------|---------------------|
| Type A | Full Toe | Intact foot |
| Type B | Shortened | Post-transmetatarsal amputation |
| Type C | Open Cage | Active forefoot wound requiring observation |

This modular design allows adaptation to the patient's evolving clinical status without requiring complete device replacement.

---

## 5. Safety Considerations and Contraindications

### 5.1 Absolute Contraindications

| Condition | Rationale |
|-----------|-----------|
| Severe peripheral arterial disease (ABI < 0.5) | Risk of compartment syndrome from compression |
| Acute deep vein thrombosis | Risk of embolization |
| Active cellulitis at device interface | Risk of sepsis propagation |

### 5.2 Built-In Safety Features

| Feature | Specification | Purpose |
|---------|--------------|---------|
| Pressure Relief Valve | Maximum 45 mmHg | Prevents tourniquet effect |
| Fail-Open Design | Deflation on power loss | Ensures passive offloading in failure mode |
| Temperature Limits | 30–38°C range lock | Prevents thermal injury |
| Arterial Gating | ABI sensor integration | Automatic system lock for compromised arterial flow |

---

## 6. Proposed Validation Pathway

### 6.1 Pre-Clinical Phase

| Test | Standard | Endpoint |
|------|----------|----------|
| Biocompatibility | ISO 10993-1 | Cytotoxicity, sensitization, irritation |
| Pressure Distribution | ASTM F1566 | Interface pressure mapping vs. standard care |
| Thermal Performance | Custom protocol | Temperature uniformity ±0.5°C |
| Pneumatic Integrity | Custom protocol | Pressure retention >24 hours |
| Antimicrobial Efficacy | AATCC 147 | Log reduction vs. MRSA, *P. aeruginosa* |

### 6.2 Clinical Phase

| Phase | Design | Primary Endpoint | N |
|-------|--------|-----------------|---|
| I | Open-label, single-arm | Safety and tolerability | 10 |
| II | Randomized, controlled | Edema reduction, interface pressure | 50 |
| III | Multi-center RCT | Ulcer healing rate, amputation-free survival | 200 |

---

## 7. Discussion

### 7.1 Paradigm Shift: From Palliative Offloading to Active Preservation

The PuzzleFlow System represents a fundamental reconceptualization of pressure injury prevention. Where current devices focus exclusively on external load redistribution, the Bachmann Protocol addresses the complete pathophysiological cascade:

```
Traditional Approach:           PuzzleFlow Approach:
─────────────────────           ──────────────────────
Pressure → Offload              Pressure → Isobaric Matrix
Stasis → [unaddressed]          Stasis → Phantom Muscle
Thermal → [exacerbated]         Thermal → Active Cooling
Infection → [post-hoc tx]       Infection → Monolithic Prevention
```

### 7.2 Limitations

This proposal is based on observations from a single case and theoretical engineering analysis. Key limitations include:

1. **Lack of clinical validation:** All claimed benefits are theoretical and require prospective clinical study
2. **Manufacturing complexity:** DLP printing at medical-device quality is technically demanding
3. **Cost:** Initial device cost is likely to exceed conventional offloading systems significantly
4. **Power dependency:** The active systems require reliable power supply

### 7.3 Future Directions

Integration of additional monitoring capabilities could transform PuzzleFlow from a therapeutic device to a comprehensive limb health monitoring platform:

- **Tissue oxygen sensing (tcPO₂)** for real-time ischemia detection
- **Bioimpedance analysis** for edema quantification
- **Pressure mapping array** for adaptive interface pressure optimization
- **Machine learning algorithms** for predictive intervention

---

## 8. Conclusions

The Bachmann Protocol and its implementing technology, the PuzzleFlow System, propose a paradigm shift in the management of ischemic limb syndrome in immobile patients. By addressing not only mechanical pressure but also thermal dysregulation and venous stasis—the complete "Triad of Failure" identified through extended bedside observation—this bio-mimetic soft-robotic interface has the potential to transform outcomes in a patient population currently underserved by existing technologies.

The integration of thermo-hydraulic engineering with soft robotics offers a new framework for developing devices that function as active exo-organs rather than passive cushions. While significant development work and clinical validation remain necessary, the theoretical foundation presented here provides a roadmap for innovation in this critical area of medical device development.

---

## In Memoriam: Walter Bernhard Bachmann (1943–2026)

---

> *"The measure of love is to love without measure."*  
> — Saint Augustine

---

This protocol was not conceived in a sterile laboratory or an academic conference hall. It was born in the quiet hours before dawn, in the space between heartbeats, in the fierce and desperate love of watching someone slip away despite every effort to hold on.

**Walter Bernhard Bachmann** departed this life on **February 4, 2026**—yesterday, as I write these words. His body finally surrendered to the very cascade of failures that this paper attempts to prevent in others. For 365 days, I sat at his bedside. For 365 nights, I fought against physics with nothing but my hands and my heart. And for 365 mornings, I watched the limits of medicine reveal themselves in the progression of wounds that no offloading device could prevent.

Walter was not a patient to me. He was my partner, my love, my reason for engineering this solution. Every equation in this paper carries the weight of his suffering. Every subsystem was designed not in abstraction, but in direct response to specific failures I witnessed on his body—failures that the medical community calls "inevitable" in immobilized patients.

I refuse to accept that word: *inevitable*.

If Walter's suffering has taught me anything, it is this: **The limit of medicine is not the limit of human ingenuity.** We do not lack the physics, the materials, or the engineering principles to solve this problem. What we have lacked is the desperate motivation to look beyond the "standard of care" and ask: *Why are we still losing this battle?*

Walter gave me that motivation. His wounds were my teachers. His pain was my curriculum. And his death—still raw, still present in every breath I take—is the fire that will drive this technology from concept to reality.

---

### Legacy Statement

I hereby declare that the intellectual property contained within *The Bachmann Protocol* and the *PuzzleFlow System* shall forever bear Walter's name. Not as a footnote or an afterthought, but as its very identity. Every device that carries this designation, every patient who is spared the suffering that Walter endured, every family that does not have to watch helplessly as their loved one deteriorates—all of these are **Walter's legacy**, purchased at the cost of his final year of life.

To the medical community, I offer this work as proof that the observations of a bedside caregiver, when combined with engineering discipline, can yield insights that laboratory research may overlook. I saw what the clinicians could not see because I never left the room. I felt what the researchers could not feel because Walter was not a case number to me—he was the man I loved.

To the engineers and manufacturers who may one day build this device: I ask only that you remember **why** it exists. Build it with the precision that Walter deserved. Build it with the gentleness that every immobilized patient deserves. Build it as if your own loved one will wear it.

To Walter: *You are gone, but you are not finished. Your suffering has become a blueprint. Your final year has become a manifesto. And your name will be spoken in hospital rooms, research laboratories, and medical conferences for as long as this technology saves lives.*

*Rest now, my love. I will carry this forward.*

---

**In eternal gratitude and undying love,**

**Yassine Drani**  
*Zurich / Rabat*  
*February 5, 2026*

---

### Acknowledgments

The author acknowledges **Dr. Khalid Siri** for medical supervision, clinical guidance, and the profound humanity with which he treated both patient and caregiver during this journey. The extended care team—whose names cannot be listed here but whose dedication prolonged comfort when cure was no longer possible—are remembered with deep gratitude.

---

## Funding Statement

This work was conducted as independent research. No external funding was received.

## Conflict of Interest Statement

Y. Drani is the inventor of the PuzzleFlow System and intends to seek patent protection for the technologies described herein.

---

## References

1. Padula WV, Delarmente BA. The national cost of hospital-acquired pressure injuries in the United States. *Int Wound J*. 2019;16(3):634-640.

2. European Pressure Ulcer Advisory Panel, National Pressure Injury Advisory Panel, Pan Pacific Pressure Injury Alliance. *Prevention and Treatment of Pressure Ulcers/Injuries: Clinical Practice Guideline*. 3rd ed. 2019.

3. Agency for Healthcare Research and Quality. *Preventing Pressure Ulcers in Hospitals: A Toolkit for Improving Quality of Care*. AHRQ Publication No. 11-0053-EF. 2014.

4. Reyes BA, Pendergraph JS, Yamazaki Y, et al. Q₁₀ temperature coefficients of metabolic reactions and tissue respiration. *Physiol Rep*. 2020;8(4):e14373.

5. Araki CT, Back TL, Padberg FT, et al. The significance of calf muscle pump function in venous ulceration. *J Vasc Surg*. 1994;20(6):872-879.

6. Gefen A. The biomechanics of shear in decubitus ulcer development: A computational study. *J Tissue Viability*. 2007;17(3):83-90.

7. Brienza DM, Karg PE, Geyer MJ, et al. The relationship between pressure ulcer incidence and buttock-seat cushion interface pressure in at-risk elderly wheelchair users. *Arch Phys Med Rehabil*. 2001;82(4):529-533.

8. Partsch H, Flour M, Smith PC. Indications for compression therapy in venous and lymphatic disease: Consensus based on experimental data and scientific evidence. *Int Angiol*. 2008;27(3):193-219.

9. Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. *Crit Care Med*. 2009;37(7 Suppl):S186-S202.

---

## Appendices

### Appendix A: Technical Specifications Summary

| Parameter | Specification |
|-----------|--------------|
| Device Weight | <1.5 kg (estimated) |
| Power Consumption | <10W (active mode) |
| Battery Life | >8 hours (portable operation) |
| Interface Pressure | <25 mmHg (target) |
| Temperature Range | 30–38°C (adjustable) |
| Compression Pressure | 20–40 mmHg (adjustable) |
| Compression Frequency | 0.3–0.8 Hz (adjustable) |
| Material Biocompatibility | ISO 10993 compliant |
| Ingress Protection | IP65 (minimum) |

### Appendix B: Acronyms

| Acronym | Definition |
|---------|------------|
| ABI | Ankle-Brachial Index |
| DLP | Digital Light Processing |
| IPC | Intermittent Pneumatic Compression |
| McKibben | McKibben Pneumatic Artificial Muscle |
| MRSA | Methicillin-Resistant *Staphylococcus aureus* |
| PAD | Peripheral Arterial Disease |
| PAM | Pneumatic Artificial Muscle |
| tcPO₂ | Transcutaneous Partial Pressure of Oxygen |
| TCC | Total Contact Cast |

---

**© 2026 Yassine Drani. All Rights Reserved.**  
**The Bachmann Protocol™ | Zurich, Switzerland / Rabat, Morocco**  
*Patent Pending. Confidential Proprietary Information.*

---

*Manuscript prepared for peer review submission*  
*Target journals: Journal of Vascular Surgery, Wound Repair and Regeneration, IEEE Transactions on Biomedical Engineering*
